Squamous cell carcinoma of head and neck+1
RecruitingStudy of MC2 TCR T Cell Therapy and Epigenetic Drug Treatment for Patients with Advanced Melanoma or Head and Neck Cancer
Study of MC2 TCR T Cell Therapy and Epigenetic Drug Treatment for Patients with Advanced Melanoma or Head and Neck Cancer
- Disease:Squamous cell carcinoma of head and neckMalignant melanoma
- Substances:Autologous Tumour-Infiltrating LymphocytesRetroviral Vector Containing The Common Gamma Chain Cdna
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Autologous Tumour-Infiltrating Lymphocytes
